BlueOcean

BlueOcean Global is a medical technology company committed to advancing the field of limb salvage through the creation of cutting-edge systems that address both bony reconstruction and soft tissue repair. Its flagship innovation, the Excelsior System™, is a next-generation external fixation platform currently in development and slated for FDA submission later in 2025. It is the first system purpose-built to support both osseous procedures and soft tissue deformity and defect correction, redefining the role of external fixation in complex lower extremity care. The Excelsior System™ is powered by FASTR™ (Fixator Assisted Soft Tissue Repair), an innovative technique designed to assist physicians in addressing limb-threatening conditions through supportive mechanical strategies. In addition, the development roadmap for the Excelsior System™ includes integrated Augmented Reality (AR) and Artificial Intelligence (AI) functionality, enabling advanced procedural planning and real-time holographic visualization during surgery. These features are designed to enhance surgical precision, reduce intraoperative risk, and make the Excelsior System™ the safest and most effective device of its kind anywhere in the world. Complementing this future-forward system, BlueOcean also offers the Sequel External Fixation System, an FDA-cleared platform designed with the clinical needs of the orthopaedic and podiatric surgeon at its core. BlueOcean's mission is to support the surgeons, and the life and limb saving procedures they perform, with breakthrough innovations that make a measurable difference and redefine the options available to patients facing limb loss.

• Employees 5
• Founded 2021